Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Lapatinib (GW572016) oral tablets|DRUG: Paclitaxel infusion|DRUG: Placebo
Sponsor: Novartis Pharmaceuticals